Loading…
A bill to establish a statute of limitations for certain actions of the Securities and Exchange Commission, and for other purposes.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,548 other S bills in the 114th — cohort avg 43d
Amends the Securities Exchange Act of 1934 to establish a 10-year statute of limitations governing an action or proceeding by the Securities and Exchange Commission for a civil monetary penalty. Tolls this statute of limitations any time an alleged violator is either absent from the United States or has no reasonably ascertainable place of abode or work within it.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2018 · fourth_quarter · Health Issues
Legislation to improve systems for identifying diversion of controlled substances and for improved reporting of information on the distribution of opioids ( S 2837 and S 2838) Legislative initiatives to modify or repeal PL 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, ie S 1960 and S 2561 Issues pertaining to pharmaceutical compounding
Client expense: Not reported · Firm income: $30,000
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. (Sponsor introductory remarks on measure: CR S6386)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: SENATE
2018 · third_quarter · Health Issues
Legislation to improve systems for identifying diversion of controlled substances and for improved reporting of information on the distribution of opioids ( S 2837 and S 2838) Legislative initiatives to modify or repeal PL 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, ie S 1960 and S 2561 Issues pertaining to pharmaceutical compounding Monitoring HR 6, opioid legislation
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2018 · second_quarter · Health Issues
Legislation to improve systems for identifying diversion of controlled substances and for improved reporting of information on the distribution of opioids ( S 2837 and S 2838) Legislative initiatives to modify or repeal PL 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, ie S 1960 and S 2561 Issues pertaining to pharmaceutical compounding
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Pharmacy
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and implementation of the Drug Quality Security Act. S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Pharmacy
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and implementation of the Drug Quality Security Act. S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
Legislative initiatives to modify or repeal PL 114-145, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, ie S 1960 and S 2561 Issues pertaining to pharmaceutical compounding
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Pharmacy
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and Implementation of the Drug Quality Security Act, S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE